DIGOXIN

DIGOXIN was reported 71873 times

DIGOXIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOACTIVE DRUG LEVEL BELOW THERAPEUTIC 62 0.9118
1 CARDIOACTIVE DRUG LEVEL DECREASED 149 0.8713
2 CARDIOACTIVE DRUG LEVEL ABOVE THERAPEUTIC 129 0.7771
3 CARDIOACTIVE DRUG LEVEL INCREASED 1017 0.7734
4 CARDIOSPASM 402 0.7204
5 IMMUNISATION 260 0.5991
6 PALMOPLANTAR KERATODERMA 392 0.5407
7 THERAPEUTIC AGENT TOXICITY 1178 0.3529
8 ATRIAL TACHYCARDIA 534 0.2540
9 VENOUS PRESSURE JUGULAR INCREASED 86 0.2369
10 PRURITUS GENITAL 397 0.1684
11 MULTIPLE INJURIES 943 0.1496
12 LEFT ATRIAL DILATATION 183 0.1434
13 SICK SINUS SYNDROME 159 0.1383
14 MITRAL VALVE CALCIFICATION 85 0.1322
15 ELECTROCARDIOGRAM ST-T CHANGE 85 0.1201
16 JUGULAR VEIN DISTENSION 68 0.1199
17 CAROTID ARTERY OCCLUSION 431 0.1180
18 NODAL ARRHYTHMIA 98 0.1138
19 BRADYARRHYTHMIA 182 0.1106
20 RIGHT ATRIAL DILATATION 56 0.1102
21 NODAL RHYTHM 160 0.1093
22 DYSPNOEA PAROXYSMAL NOCTURNAL 78 0.1070
23 DILATATION ATRIAL 118 0.1011
24 AORTIC VALVE SCLEROSIS 74 0.1010
25 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 78 0.0957
26 SLEEP TERROR 398 0.0944
27 TENSION HEADACHE 406 0.0943
28 ISCHAEMIC CARDIOMYOPATHY 289 0.0942
29 ECONOMIC PROBLEM 1394 0.0919
30 HYDROPS FOETALIS 54 0.0881
31 ORTHOPNOEA 275 0.0863
32 DILATATION VENTRICULAR 178 0.0846
33 ECHOCARDIOGRAM ABNORMAL 117 0.0836
34 MITRAL VALVE STENOSIS 55 0.0821
35 ATRIOVENTRICULAR BLOCK FIRST DEGREE 327 0.0754
36 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 58 0.0744
37 VENTRICULAR TACHYCARDIA 1221 0.0739
38 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 155 0.0705
39 TRICUSPID VALVE INCOMPETENCE 556 0.0699
40 COR PULMONALE 65 0.0681
41 BUNDLE BRANCH BLOCK LEFT 280 0.0660
42 MITRAL VALVE INCOMPETENCE 741 0.0654
43 CONDUCTION DISORDER 118 0.0643
44 INTERNATIONAL NORMALISED RATIO INCREASED 1802 0.0631
45 ACUTE PRERENAL FAILURE 73 0.0630
46 BRASH SYNDROME 88 0.0627
47 PULMONARY VALVE INCOMPETENCE 91 0.0622
48 LEFT VENTRICULAR HYPERTROPHY 260 0.0607
49 COLONIC POLYP 99 0.0599
50 AORTIC VALVE INCOMPETENCE 254 0.0596
51 RHONCHI 82 0.0593
52 HEPATIC CONGESTION 56 0.0591
53 ATRIAL FLUTTER 460 0.0576
54 CARDIOMEGALY 698 0.0567
55 CONGESTIVE CARDIOMYOPATHY 236 0.0566
56 HAEMORRHAGIC ANAEMIA 247 0.0561
57 IMPLANTABLE DEFIBRILLATOR INSERTION 74 0.0559
58 BRAIN NATRIURETIC PEPTIDE INCREASED 172 0.0557
59 SUBARACHNOID HAEMORRHAGE 562 0.0551
60 RIGHT VENTRICULAR FAILURE 385 0.0549
61 CARDIAC MURMUR 470 0.0543
62 INTERNATIONAL NORMALISED RATIO DECREASED 219 0.0540
63 LEFT VENTRICULAR DYSFUNCTION 351 0.0523
64 PULMONARY ARTERIAL PRESSURE INCREASED 85 0.0521
65 AORTIC STENOSIS 180 0.0516
66 CARDIOVERSION 72 0.0515
67 ATRIOVENTRICULAR BLOCK SECOND DEGREE 151 0.0497
68 SUPRAVENTRICULAR EXTRASYSTOLES 166 0.0491
69 VENTRICULAR HYPOKINESIA 157 0.0488
70 INTERNATIONAL NORMALISED RATIO FLUCTUATION 101 0.0488
71 FACIAL PAIN 431 0.0482
72 BRADYCARDIA 2538 0.0478
73 ELECTROCARDIOGRAM T WAVE ABNORMAL 74 0.0474
74 ARRHYTHMIA SUPRAVENTRICULAR 51 0.0467
75 PROTHROMBIN TIME PROLONGED 278 0.0464
76 RENAL FAILURE CHRONIC 357 0.0464
77 TACHYARRHYTHMIA 114 0.0456
78 ATRIOVENTRICULAR BLOCK COMPLETE 304 0.0454
79 VENTRICULAR HYPERTROPHY 110 0.0438
80 VENTRICULAR EXTRASYSTOLES 455 0.0438
81 OCCULT BLOOD POSITIVE 85 0.0432
82 BUNDLE BRANCH BLOCK RIGHT 198 0.0431
83 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 60 0.0427
84 ISCHAEMIC HEPATITIS 58 0.0423
85 ATRIAL FIBRILLATION 4066 0.0417
86 CAROTID ARTERY STENOSIS 145 0.0415
87 TORSADE DE POINTES 324 0.0413
88 PULMONARY HYPERTENSION 857 0.0411
89 INTERMITTENT CLAUDICATION 65 0.0410
90 ESSENTIAL HYPERTENSION 75 0.0409
91 SINUS BRADYCARDIA 394 0.0407
92 LEFT VENTRICULAR FAILURE 136 0.0395
93 ATRIOVENTRICULAR BLOCK 304 0.0393
94 INTERNATIONAL NORMALISED RATIO ABNORMAL 135 0.0392
95 CARDIAC FAILURE CONGESTIVE 3144 0.0391
96 CARDIAC FAILURE CHRONIC 165 0.0387
97 MITRAL VALVE DISEASE 68 0.0384
98 LOWER GASTROINTESTINAL HAEMORRHAGE 283 0.0382
99 ALVEOLITIS 54 0.0382
100 RALES 222 0.0382
101 ABDOMINAL WALL HAEMATOMA 74 0.0379
102 AORTIC ARTERIOSCLEROSIS 97 0.0377
103 VASCULITIS 439 0.0376
104 VENTRICULAR ARRHYTHMIA 137 0.0374
105 VENTRICULAR FIBRILLATION 410 0.0369
106 HYPERKALAEMIA 1282 0.0365
107 VENTRICULAR DYSFUNCTION 94 0.0362
108 LOBAR PNEUMONIA 67 0.0362
109 CARDIOMYOPATHY 534 0.0361
110 CARDIAC VALVE DISEASE 206 0.0360
111 DIASTOLIC DYSFUNCTION 110 0.0356
112 ELECTROCARDIOGRAM ABNORMAL 279 0.0355
113 HYPERTENSIVE HEART DISEASE 66 0.0353
114 RENAL FAILURE ACUTE 1491 0.0351
115 ATELECTASIS 329 0.0340
116 COMPUTERISED TOMOGRAM ABNORMAL 75 0.0331
117 SINUS NODE DYSFUNCTION 60 0.0327
118 BREATH SOUNDS ABNORMAL 161 0.0326
119 HYPOVOLAEMIA 189 0.0323
120 HEART RATE IRREGULAR 716 0.0317
121 CEREBRAL ATROPHY 126 0.0316
122 BLOOD CHLORIDE DECREASED 81 0.0314
123 CHEST X-RAY ABNORMAL 96 0.0313
124 EJECTION FRACTION DECREASED 484 0.0311
125 EMBOLIC STROKE 108 0.0306
126 ORAL INTAKE REDUCED 74 0.0306
127 CREPITATIONS 91 0.0305
128 SUPRAVENTRICULAR TACHYCARDIA 291 0.0304
129 FAMILY STRESS 93 0.0300
130 PERIPHERAL VASCULAR DISORDER 154 0.0299
131 BLOOD UREA INCREASED 487 0.0291
132 ANOSMIA 420 0.0290
133 UPPER GASTROINTESTINAL HAEMORRHAGE 486 0.0289
134 CARDIAC PACEMAKER INSERTION 171 0.0287
135 AORTIC VALVE STENOSIS 51 0.0286
136 DIVERTICULUM 203 0.0285
137 ATRIAL THROMBOSIS 59 0.0285
138 CARDIAC FAILURE ACUTE 189 0.0283
139 ANGINA UNSTABLE 184 0.0283
140 PULMONARY ARTERIAL HYPERTENSION 408 0.0281
141 MELAENA 615 0.0279
142 ARTERIOSCLEROSIS CORONARY ARTERY 185 0.0279
143 MYOCARDIAL ISCHAEMIA 316 0.0277
144 INTRACARDIAC THROMBUS 85 0.0277
145 COAGULOPATHY 456 0.0273
146 SOCIAL PROBLEM 113 0.0273
147 PERICARDITIS 457 0.0272
148 PULSE ABSENT 129 0.0271
149 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 137 0.0270
150 HYPERLIPIDAEMIA 322 0.0269
151 CORONARY ARTERY DISEASE 807 0.0266
152 ANOREXIA 333 0.0258
153 AZOTAEMIA 102 0.0255
154 TRANSIENT ISCHAEMIC ATTACK 856 0.0253
155 CARDIOGENIC SHOCK 359 0.0250
156 ARTERIOSCLEROSIS 233 0.0247
157 CARDIAC FAILURE 1975 0.0246
158 RETROPERITONEAL HAEMATOMA 54 0.0244
159 MULTI-ORGAN FAILURE 418 0.0242
160 HEART INJURY 60 0.0241
161 FLUID OVERLOAD 351 0.0241
162 EXCORIATION 61 0.0240
163 DYSLIPIDAEMIA 122 0.0240
164 INFUSION SITE INFECTION 55 0.0236
165 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 121 0.0236
166 DIVERTICULUM INTESTINAL HAEMORRHAGIC 53 0.0236
167 ELECTROCARDIOGRAM T WAVE INVERSION 52 0.0235
168 SUBDURAL HAEMATOMA 336 0.0234
169 EXTRASYSTOLES 161 0.0230
170 OXYGEN CONSUMPTION INCREASED 55 0.0230
171 URINE OUTPUT DECREASED 200 0.0229
172 BLOOD POTASSIUM INCREASED 369 0.0227
173 GASTROINTESTINAL HAEMORRHAGE 1886 0.0225
174 CORONARY ARTERY STENOSIS 112 0.0222
175 STUPOR 71 0.0221
176 BENIGN PROSTATIC HYPERPLASIA 114 0.0221
177 VISUAL DISTURBANCE 126 0.0219
178 RETROPERITONEAL HAEMORRHAGE 54 0.0219
179 IRON DEFICIENCY ANAEMIA 202 0.0219
180 PULMONARY CONGESTION 286 0.0217
181 ECCHYMOSIS 148 0.0216
182 ARRHYTHMIA 1021 0.0215
183 LUNG INFILTRATION 189 0.0214
184 NORMOCHROMIC NORMOCYTIC ANAEMIA 64 0.0213
185 PERIPHERAL ISCHAEMIA 87 0.0213
186 CREATININE RENAL CLEARANCE DECREASED 85 0.0212
187 CATHETERISATION CARDIAC 94 0.0212
188 NEPHROGENIC SYSTEMIC FIBROSIS 64 0.0212
189 DIPLOPIA 550 0.0212
190 BLOOD CULTURE POSITIVE 63 0.0210
191 HEART RATE DECREASED 737 0.0210
192 LOSS OF EMPLOYMENT 63 0.0208
193 ABDOMINAL TENDERNESS 103 0.0207
194 MUSCLE TWITCHING 477 0.0207
195 DEVICE INFUSION ISSUE 51 0.0205
196 ACUTE RESPIRATORY FAILURE 387 0.0201
197 HAEMOTHORAX 58 0.0200
198 REFUSAL OF TREATMENT BY PATIENT 130 0.0199
199 DYSPNOEA EXERTIONAL 749 0.0199
200 ISCHAEMIA 91 0.0198
201 RENAL CYST 157 0.0197
202 ANURIA 170 0.0197
203 OLIGURIA 122 0.0196
204 FAILURE TO THRIVE 102 0.0196
205 PULSELESS ELECTRICAL ACTIVITY 82 0.0196
206 PEPTIC ULCER 65 0.0196
207 DUODENAL ULCER HAEMORRHAGE 56 0.0196
208 EXERCISE TOLERANCE DECREASED 112 0.0194
209 SUBDURAL HAEMORRHAGE 53 0.0194
210 ENDOTRACHEAL INTUBATION 53 0.0189
211 SPINAL OSTEOARTHRITIS 166 0.0189
212 HEART VALVE INCOMPETENCE 54 0.0188
213 METABOLIC ENCEPHALOPATHY 56 0.0186
214 DRUG TOXICITY 254 0.0186
215 DIFFICULTY IN WALKING 64 0.0186
216 PLEURAL EFFUSION 1126 0.0185
217 ANHEDONIA 486 0.0185
218 HYPERCAPNIA 55 0.0182
219 GASTRITIS EROSIVE 85 0.0182
220 DRUG INTERACTION 2890 0.0182
221 ACUTE PULMONARY OEDEMA 102 0.0182
222 BLOOD PRESSURE DIASTOLIC DECREASED 134 0.0181
223 ORTHOSTATIC HYPOTENSION 315 0.0181
224 INFUSION SITE HAEMORRHAGE 59 0.0179
225 INJURY 1260 0.0179
226 PROTEIN TOTAL DECREASED 67 0.0178
227 DECUBITUS ULCER 145 0.0178
228 DRUG LEVEL INCREASED 294 0.0177
229 PULMONARY OEDEMA 792 0.0177
230 PHARMACEUTICAL PRODUCT COMPLAINT 459 0.0177
231 STAPHYLOCOCCAL SEPSIS 87 0.0176
232 PRESYNCOPE 425 0.0175
233 RESPIRATORY ACIDOSIS 68 0.0173
234 POTENTIATING DRUG INTERACTION 58 0.0173
235 HAEMODIALYSIS 145 0.0172
236 CEREBROVASCULAR DISORDER 52 0.0172
237 HAEMATOMA 445 0.0172
238 CARDIAC FLUTTER 111 0.0172
239 HYPOXIA 604 0.0171
240 SUDDEN CARDIAC DEATH 58 0.0170
241 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 886 0.0170
242 DUODENITIS 52 0.0169
243 HEART RATE ABNORMAL 94 0.0168
244 BLOOD CREATINE INCREASED 74 0.0167
245 OEDEMA PERIPHERAL 2037 0.0167
246 HAEMATURIA 571 0.0167
247 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 68 0.0166
248 NEPHROGENIC ANAEMIA 77 0.0166
249 CEREBRAL ISCHAEMIA 85 0.0165
250 HAEMATOCRIT DECREASED 327 0.0165
251 AORTIC ANEURYSM 125 0.0164
252 BRONCHOPNEUMONIA 56 0.0163
253 HAEMORRHAGE INTRACRANIAL 244 0.0163
254 MENTAL STATUS CHANGES 453 0.0163
255 ACUTE MYOCARDIAL INFARCTION 479 0.0162
256 HYPOTENSION 3258 0.0162
257 RENAL FAILURE 2156 0.0162
258 CARDIAC ARREST 1332 0.0161
259 EPIGASTRIC DISCOMFORT 63 0.0161
260 PAIN OF SKIN 433 0.0161
261 SUDDEN DEATH 170 0.0160
262 PERICARDIAL EFFUSION 370 0.0160
263 HYPERVOLAEMIA 79 0.0160
264 SHOCK HAEMORRHAGIC 130 0.0160
265 CANDIDIASIS 64 0.0159
266 RHINITIS ALLERGIC 71 0.0159
267 CACHEXIA 82 0.0159
268 RECTAL HAEMORRHAGE 684 0.0159
269 CORONARY ARTERY BYPASS 90 0.0156
270 CARDIOPULMONARY FAILURE 61 0.0156
271 HYPERTHYROIDISM 223 0.0154
272 BLOOD PRESSURE SYSTOLIC DECREASED 70 0.0154
273 TROPONIN INCREASED 117 0.0154
274 BLOOD ALBUMIN DECREASED 121 0.0152
275 LUNG NEOPLASM 65 0.0152
276 RASH PAPULAR 340 0.0152
277 HYPOMAGNESAEMIA 210 0.0151
278 SINUS TACHYCARDIA 214 0.0151
279 CYANOSIS 236 0.0150
280 HYPONATRAEMIA 845 0.0150
281 HAEMOPTYSIS 418 0.0150
282 INFUSION SITE PAIN 193 0.0150
283 TOXICITY TO VARIOUS AGENTS 2509 0.0149
284 LIP SWELLING 495 0.0148
285 HEART RATE INCREASED 1458 0.0147
286 CLOSTRIDIUM DIFFICILE COLITIS 156 0.0147
287 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 130 0.0147
288 RESPIRATORY FAILURE 1069 0.0146
289 DEHYDRATION 1953 0.0146
290 HAEMORRHAGIC STROKE 114 0.0146
291 FLUID RETENTION 736 0.0145
292 EMPHYSEMA 145 0.0144
293 OEDEMA 779 0.0143
294 LEUKOCYTOSIS 258 0.0142
295 UNRESPONSIVE TO STIMULI 367 0.0142
296 CORONARY ARTERIAL STENT INSERTION 72 0.0142
297 DUODENAL ULCER 100 0.0142
298 DIABETIC NEUROPATHY 70 0.0141
299 MALNUTRITION 157 0.0140
300 PALPITATIONS 1643 0.0140
301 HEPARIN-INDUCED THROMBOCYTOPENIA 69 0.0140
302 SYNCOPE 1392 0.0139
303 FEAR 374 0.0139
304 GASTRIC ULCER HAEMORRHAGE 77 0.0139
305 CARDIO-RESPIRATORY ARREST 581 0.0139
306 INFUSION SITE SWELLING 87 0.0138
307 HIATUS HERNIA 179 0.0138
308 HAEMOGLOBIN INCREASED 63 0.0138
309 INTESTINAL ISCHAEMIA 76 0.0138
310 TACHYCARDIA 1209 0.0136
311 HYPOKALAEMIA 627 0.0136
312 BLOOD CREATININE INCREASED 883 0.0135
313 INFUSION SITE ERYTHEMA 114 0.0135
314 LACERATION 127 0.0135
315 ABNORMAL LOSS OF WEIGHT 92 0.0135
316 HYPOVOLAEMIC SHOCK 64 0.0133
317 ACIDOSIS 102 0.0133
318 SPINAL COLUMN STENOSIS 63 0.0133
319 GENERALISED OEDEMA 165 0.0133
320 DIZZINESS POSTURAL 129 0.0133
321 ELECTROLYTE IMBALANCE 154 0.0132
322 STOMACH DISCOMFORT 68 0.0132
323 HEPATOMEGALY 129 0.0131
324 RESPIRATORY DISTRESS 362 0.0131
325 BLINDNESS 533 0.0131
326 CARDIAC TAMPONADE 62 0.0130
327 ISCHAEMIC STROKE 232 0.0130
328 HAEMODYNAMIC INSTABILITY 99 0.0130
329 GOUT 233 0.0130
330 EYE PRURITUS 436 0.0130
331 SOCIAL AVOIDANT BEHAVIOUR 75 0.0129
332 CIRCULATORY COLLAPSE 220 0.0129
333 UROSEPSIS 119 0.0129
334 TRANSFUSION 135 0.0129
335 MULTIPLE MYELOMA 60 0.0129
336 EPISTAXIS 963 0.0129
337 HAEMATEMESIS 325 0.0128
338 SLEEP APNOEA SYNDROME 244 0.0128
339 CARDIAC DISORDER 1195 0.0128
340 BLOOD LACTIC ACID INCREASED 67 0.0127
341 CEREBRAL HAEMORRHAGE 455 0.0127
342 ANGIOEDEMA 562 0.0127
343 HAEMORRHOIDAL HAEMORRHAGE 62 0.0127
344 COGNITIVE DISORDER 592 0.0127
345 DRUG LEVEL ABOVE THERAPEUTIC 58 0.0126
346 STAPHYLOCOCCAL BACTERAEMIA 55 0.0126
347 MYOCARDIAL INFARCTION 2203 0.0126
348 DERMATITIS EXFOLIATIVE 63 0.0126
349 DIVERTICULUM INTESTINAL 55 0.0126
350 ENDOCARDITIS 64 0.0125
351 UNEVALUABLE EVENT 942 0.0124
352 HYPERCHOLESTEROLAEMIA 120 0.0124
353 ANGINA PECTORIS 356 0.0124
354 GASTRIC ULCER 236 0.0124
355 VASCULAR DEVICE INFECTION 56 0.0123
356 METABOLIC ACIDOSIS 394 0.0123
357 ASCITES 361 0.0123
358 RESPIRATORY RATE INCREASED 109 0.0123
359 CORONARY ARTERY OCCLUSION 168 0.0122
360 CHEST PAIN 2267 0.0122
361 LOW BIRTH WEIGHT BABY 97 0.0122
362 BLOOD SODIUM DECREASED 230 0.0122
363 FAECES DISCOLOURED 263 0.0121
364 RENAL INJURY 360 0.0121
365 DIALYSIS 171 0.0120
366 HALLUCINATION 904 0.0120
367 FLANK PAIN 112 0.0119
368 BLOOD PRESSURE DECREASED 781 0.0117
369 HEMIPARESIS 198 0.0117
370 ANAEMIA 2210 0.0116
371 INTERNAL HAEMORRHAGE 132 0.0115
372 NOCTURIA 139 0.0114
373 TINNITUS 523 0.0114
374 ELECTROCARDIOGRAM QT PROLONGED 409 0.0114
375 HYPOGLYCAEMIA 551 0.0113
376 FEMORAL NECK FRACTURE 58 0.0113
377 ACUTE KIDNEY INJURY 1727 0.0113
378 HYPERNATRAEMIA 56 0.0112
379 POLYURIA 92 0.0112
380 LETHARGY 646 0.0112
381 CEREBRAL INFARCTION 274 0.0112
382 CELLULITIS 559 0.0111
383 AMNESIA 721 0.0111
384 GASTRITIS 291 0.0110
385 FAECAL INCONTINENCE 53 0.0110
386 LIVER FUNCTION TEST ABNORMAL 320 0.0110
387 PRODUCTIVE COUGH 525 0.0110
388 DYSPNOEA 6218 0.0110
389 DISORIENTATION 433 0.0109
390 CONFUSIONAL STATE 1764 0.0109
391 BLOOD ALKALINE PHOSPHATASE INCREASED 271 0.0109
392 OESOPHAGITIS 119 0.0109
393 ACUTE CORONARY SYNDROME 90 0.0109
394 ASPIRATION 119 0.0109
395 CHOLECYSTITIS 129 0.0108
396 GLOMERULAR FILTRATION RATE DECREASED 133 0.0108
397 TACHYPNOEA 147 0.0108
398 ABASIA 267 0.0108
399 OXYGEN SATURATION DECREASED 601 0.0107
400 PNEUMONIA ASPIRATION 266 0.0106
401 RENAL IMPAIRMENT 894 0.0106
402 MOUTH HAEMORRHAGE 78 0.0106
403 DIABETES MELLITUS INADEQUATE CONTROL 188 0.0106
404 BLOOD URIC ACID INCREASED 61 0.0106
405 HYPOPHAGIA 268 0.0105
406 APNOEA 81 0.0104
407 HEAD INJURY 328 0.0104
408 BLOOD PRESSURE INADEQUATELY CONTROLLED 62 0.0103
409 VARICOSE VEIN 53 0.0103
410 ANEURYSM 51 0.0102
411 DISTURBANCE IN ATTENTION 552 0.0102
412 PULMONARY HAEMORRHAGE 80 0.0102
413 HAEMOGLOBIN DECREASED 1048 0.0102
414 PAIN IN JAW 288 0.0102
415 GASTROENTERITIS 147 0.0101
416 CHOLECYSTITIS ACUTE 57 0.0100
417 BLOOD PRESSURE SYSTOLIC INCREASED 196 0.0100
418 CONCOMITANT DISEASE AGGRAVATED 62 0.0100
419 SOPOR 133 0.0100
420 DELIRIUM 348 0.0100
421 WALKING AID USER 66 0.0100
422 CHOLELITHIASIS 327 0.0100
423 PETECHIAE 103 0.0099
424 ACTIVITIES OF DAILY LIVING IMPAIRED 195 0.0098
425 HAEMORRHOIDS 192 0.0098
426 HYPERGLYCAEMIA 357 0.0098
427 GANGRENE 59 0.0098
428 ASTHENIA 3662 0.0097
429 SKIN ULCER 251 0.0097
430 SEPSIS 1082 0.0097
431 PULMONARY FIBROSIS 186 0.0097
432 PERIPHERAL COLDNESS 133 0.0097
433 TOXIC EPIDERMAL NECROLYSIS 145 0.0095
434 MEDICATION ERROR 530 0.0095
435 DEMENTIA 264 0.0094
436 ARTERIAL OCCLUSIVE DISEASE 74 0.0094
437 SPLENOMEGALY 110 0.0094
438 BLOOD URINE PRESENT 177 0.0093
439 ULCER HAEMORRHAGE 63 0.0093
440 BLOOD POTASSIUM DECREASED 277 0.0092
441 DIZZINESS 4566 0.0091
442 MUSCULOSKELETAL CHEST PAIN 140 0.0090
443 MUSCULAR WEAKNESS 1028 0.0090
444 HEMIPLEGIA 75 0.0090
445 LACTIC ACIDOSIS 291 0.0090
446 CEREBROVASCULAR ACCIDENT 1518 0.0090
447 SPINAL COMPRESSION FRACTURE 74 0.0089
448 MYOPATHY 77 0.0089
449 DEVICE RELATED INFECTION 137 0.0089
450 DECREASED ACTIVITY 96 0.0089
451 HYPOTHYROIDISM 284 0.0089
452 FALL 2957 0.0089
453 RIB FRACTURE 182 0.0088
454 BLOOD BILIRUBIN INCREASED 239 0.0088
455 SHOCK 203 0.0088
456 BLOOD MAGNESIUM DECREASED 76 0.0088
457 GINGIVAL BLEEDING 120 0.0088
458 SPUTUM DISCOLOURED 83 0.0087
459 INGUINAL HERNIA 53 0.0087
460 DERMATITIS CONTACT 99 0.0087
461 OBESITY 138 0.0087
462 BLOOD CALCIUM DECREASED 97 0.0086
463 PURPURA 76 0.0086
464 PNEUMONIA 2775 0.0086
465 LOSS OF CONSCIOUSNESS 1095 0.0085
466 INTERVERTEBRAL DISC DEGENERATION 79 0.0085
467 COLITIS ISCHAEMIC 57 0.0084
468 BACTERAEMIA 100 0.0084
469 HYPERHIDROSIS 1082 0.0084
470 SEPTIC SHOCK 364 0.0084
471 PALLOR 227 0.0083
472 APHASIA 251 0.0083
473 HYPOTHERMIA 84 0.0083
474 SKIN LACERATION 90 0.0083
475 WHITE BLOOD CELL COUNT INCREASED 317 0.0083
476 CARDIAC OPERATION 71 0.0083
477 RENAL TUBULAR NECROSIS 81 0.0082
478 JAUNDICE 222 0.0082
479 MYOSITIS 74 0.0082
480 DEPRESSED LEVEL OF CONSCIOUSNESS 325 0.0082
481 RESPIRATORY ARREST 226 0.0082
482 INCOHERENT 53 0.0082
483 HEPATITIS ACUTE 53 0.0081
484 BODY HEIGHT DECREASED 87 0.0081
485 INCONTINENCE 86 0.0081
486 POLYP 53 0.0081
487 BLOOD TRIGLYCERIDES INCREASED 143 0.0081
488 PELVIC FRACTURE 63 0.0081
489 DYSURIA 296 0.0080
490 HYDRONEPHROSIS 60 0.0080
491 END STAGE RENAL DISEASE 146 0.0080
492 ASPARTATE AMINOTRANSFERASE INCREASED 425 0.0080
493 PULMONARY MASS 119 0.0080
494 ENCEPHALOPATHY 196 0.0080
495 NEUTROPENIC SEPSIS 57 0.0080
496 EMOTIONAL DISORDER 244 0.0079
497 POST PROCEDURAL HAEMORRHAGE 92 0.0079
498 MYOCLONUS 94 0.0079
499 SMALL INTESTINAL OBSTRUCTION 97 0.0079
500 MACULAR DEGENERATION 94 0.0079
501 HYPOKINESIA 114 0.0078
502 CHEST DISCOMFORT 803 0.0078
503 DYSARTHRIA 295 0.0078
504 GASTRIC HAEMORRHAGE 90 0.0078
505 HYPERBILIRUBINAEMIA 81 0.0078
506 HALLUCINATION, VISUAL 165 0.0078
507 POST PROCEDURAL COMPLICATION 150 0.0078
508 PREMATURE BABY 235 0.0078
509 CONTUSION 749 0.0078
510 URINARY RETENTION 259 0.0078
511 DIABETES MELLITUS 589 0.0077
512 ROTATOR CUFF SYNDROME 99 0.0077
513 EMBOLISM 64 0.0077
514 TREATMENT NONCOMPLIANCE 421 0.0077
515 HYPERCALCAEMIA 95 0.0077
516 STAPHYLOCOCCAL INFECTION 253 0.0077
517 HEPATIC FAILURE 231 0.0077
518 OSTEOARTHRITIS 324 0.0076
519 DECREASED APPETITE 1773 0.0076
520 RHABDOMYOLYSIS 318 0.0076
521 BRONCHITIS 563 0.0076
522 ATAXIA 90 0.0076
523 BLOOD GLUCOSE INCREASED 1426 0.0076
524 WEIGHT DECREASED 2112 0.0076
525 URINARY INCONTINENCE 224 0.0076
526 HYPOTONIA 75 0.0075
527 LUNG DISORDER 368 0.0075
528 PNEUMOTHORAX 119 0.0075
529 ANXIETY 2128 0.0075
530 LABORATORY TEST ABNORMAL 219 0.0074
531 ESCHERICHIA INFECTION 61 0.0074
532 URINARY TRACT INFECTION 1251 0.0073
533 MYELODYSPLASTIC SYNDROME 106 0.0073
534 VISUAL IMPAIRMENT 908 0.0073
535 VOMITING 3443 0.0073
536 MULTIPLE ORGAN DYSFUNCTION SYNDROME 207 0.0073
537 BASAL CELL CARCINOMA 114 0.0073
538 PROCEDURAL COMPLICATION 56 0.0073
539 NO THERAPEUTIC RESPONSE 89 0.0073
540 BLOOD CALCIUM INCREASED 64 0.0073
541 HEPATIC CIRRHOSIS 137 0.0073
542 OSTEOPENIA 110 0.0072
543 HIP FRACTURE 232 0.0072
544 TENDERNESS 75 0.0072
545 STENT PLACEMENT 58 0.0072
546 PERIPHERAL SWELLING 1106 0.0072
547 ALTERED STATE OF CONSCIOUSNESS 155 0.0071
548 LUNG INFECTION 111 0.0071
549 WEIGHT FLUCTUATION 74 0.0071
550 LOCALISED INFECTION 171 0.0071
551 HAEMARTHROSIS 63 0.0070
552 CHROMATURIA 157 0.0069
553 HAEMORRHAGE 727 0.0069
554 GROIN PAIN 61 0.0069
555 HYPOALBUMINAEMIA 54 0.0069
556 ALANINE AMINOTRANSFERASE INCREASED 426 0.0069
557 BRONCHOSPASM 99 0.0069
558 EYE HAEMORRHAGE 92 0.0069
559 HYPERTENSION 1455 0.0069
560 THROMBOCYTOPENIA 757 0.0068
561 BLOOD LACTATE DEHYDROGENASE INCREASED 107 0.0067
562 NEPHROPATHY 63 0.0067
563 BODY TEMPERATURE DECREASED 66 0.0067
564 ATRIAL SEPTAL DEFECT 56 0.0067
565 BACK PAIN 1552 0.0067
566 DISSEMINATED INTRAVASCULAR COAGULATION 94 0.0067
567 POLLAKIURIA 278 0.0067
568 HYPOCALCAEMIA 126 0.0067
569 ILL-DEFINED DISORDER 404 0.0066
570 PNEUMONIA BACTERIAL 61 0.0066
571 INCREASED TENDENCY TO BRUISE 61 0.0066
572 HYPERSOMNIA 190 0.0066
573 GENERAL PHYSICAL HEALTH DETERIORATION 766 0.0066
574 COLD SWEAT 116 0.0066
575 CONVULSION 376 0.0066
576 SEASONAL ALLERGY 93 0.0066
577 BEDRIDDEN 86 0.0065
578 GAMMA-GLUTAMYLTRANSFERASE INCREASED 145 0.0065
579 CARDIOVASCULAR DISORDER 166 0.0065
580 DYSPHAGIA 620 0.0065
581 ILEUS 81 0.0065
582 MEMORY IMPAIRMENT 892 0.0065
583 DYSSTASIA 187 0.0064
584 INTENTIONAL PRODUCT MISUSE 560 0.0064
585 MUSCLE ATROPHY 81 0.0064
586 COMA 304 0.0064
587 WHEEZING 378 0.0064
588 TYPE 2 DIABETES MELLITUS 214 0.0064
589 PANCYTOPENIA 355 0.0063
590 UPPER RESPIRATORY TRACT INFECTION 292 0.0063
591 DEFORMITY 59 0.0063
592 RESPIRATORY DISORDER 188 0.0063
593 PNEUMONITIS 171 0.0063
594 BALANCE DISORDER 542 0.0063
595 SINUS CONGESTION 84 0.0062
596 RENAL DISORDER 289 0.0062
597 NECK PAIN 345 0.0062
598 PREMATURE DELIVERY 98 0.0061
599 NAUSEA 4866 0.0061
600 DIVERTICULITIS 170 0.0061
601 ABDOMINAL DISCOMFORT 1027 0.0061
602 MUSCULOSKELETAL DISCOMFORT 105 0.0061
603 ORAL CANDIDIASIS 80 0.0061
604 PSEUDOMONAS INFECTION 52 0.0061
605 COUGH 1699 0.0061
606 RED BLOOD CELL COUNT DECREASED 173 0.0060
607 BLOOD PRESSURE FLUCTUATION 145 0.0060
608 COLON CANCER 90 0.0060
609 DIARRHOEA 3896 0.0060
610 HAEMATOCHEZIA 333 0.0060
611 PROSTATIC SPECIFIC ANTIGEN INCREASED 83 0.0060
612 EXOSTOSIS 55 0.0060
613 MALAISE 2625 0.0060
614 MIGRAINE 571 0.0060
615 OSTEOMYELITIS 108 0.0060
616 ACUTE RESPIRATORY DISTRESS SYNDROME 105 0.0059
617 MUSCULOSKELETAL PAIN 311 0.0059
618 BURSITIS 72 0.0059
619 ABDOMINAL DISTENSION 618 0.0059
620 RETCHING 126 0.0059
621 ULCER 94 0.0059
622 BLOOD IRON DECREASED 70 0.0059
623 CHRONIC KIDNEY DISEASE 447 0.0059
624 LOWER RESPIRATORY TRACT INFECTION 267 0.0059
625 ABDOMINAL PAIN 1361 0.0058
626 ABDOMINAL PAIN UPPER 1204 0.0058
627 LOCAL SWELLING 102 0.0058
628 GASTROOESOPHAGEAL REFLUX DISEASE 465 0.0058
629 HOSPICE CARE 57 0.0058
630 MUSCLE RIGIDITY 69 0.0058
631 OBSTRUCTIVE AIRWAYS DISORDER 64 0.0057
632 INITIAL INSOMNIA 59 0.0057
633 JOINT RANGE OF MOTION DECREASED 77 0.0057
634 DRUG PRESCRIBING ERROR 109 0.0057
635 PYREXIA 1961 0.0057
636 DELUSION 88 0.0057
637 RESPIRATORY TRACT INFECTION 147 0.0056
638 CONDITION AGGRAVATED 1713 0.0056
639 VISION BLURRED 770 0.0056
640 PARALYSIS 80 0.0056
641 TOXIC SKIN ERUPTION 56 0.0056
642 FEELING ABNORMAL 1331 0.0055
643 DYSPEPSIA 546 0.0055
644 FLUSHING 564 0.0055
645 CLOSTRIDIUM DIFFICILE INFECTION 121 0.0055
646 VISUAL ACUITY REDUCED 183 0.0055
647 FATIGUE 4288 0.0055
648 SKIN LESION 151 0.0055
649 WOUND INFECTION 60 0.0055
650 JOINT INJURY 117 0.0055
651 BLOOD CREATINE PHOSPHOKINASE INCREASED 157 0.0054
652 PLATELET COUNT DECREASED 580 0.0054
653 RESTLESSNESS 199 0.0054
654 BLOOD THYROID STIMULATING HORMONE INCREASED 50 0.0054
655 SKIN DISCOLOURATION 248 0.0054
656 HEPATITIS 138 0.0054
657 AGRANULOCYTOSIS 100 0.0054
658 MOTOR DYSFUNCTION 54 0.0053
659 DYSPHONIA 308 0.0053
660 GALLBLADDER DISORDER 94 0.0053
661 INSOMNIA 1400 0.0053
662 BLADDER DISORDER 52 0.0052
663 PARKINSONISM 51 0.0052
664 RESTLESS LEGS SYNDROME 95 0.0052
665 ACCIDENTAL OVERDOSE 191 0.0052
666 STEVENS-JOHNSON SYNDROME 116 0.0052
667 BONE DISORDER 95 0.0052
668 EATING DISORDER 111 0.0052
669 SPEECH DISORDER 273 0.0052
670 MENTAL DISORDER 224 0.0051
671 RESPIRATORY DEPRESSION 63 0.0051
672 NASAL CONGESTION 301 0.0051
673 LIMB INJURY 139 0.0051
674 HEPATIC STEATOSIS 95 0.0051
675 POISONING 64 0.0051
676 DEAFNESS 133 0.0051
677 WOUND 142 0.0051
678 BLOOD PRESSURE ABNORMAL 101 0.0051
679 INTENTIONAL PRODUCT USE ISSUE 442 0.0050
680 PAIN IN EXTREMITY 1484 0.0050
681 BLINDNESS UNILATERAL 71 0.0050
682 C-REACTIVE PROTEIN INCREASED 183 0.0050
683 WRIST FRACTURE 60 0.0050
684 THYROID DISORDER 77 0.0050
685 CATARACT 297 0.0050
686 PAIN 3062 0.0050
687 LIVER DISORDER 221 0.0050
688 RESPIRATORY TRACT CONGESTION 79 0.0050
689 DENTAL CARIES 55 0.0050
690 BREAST PAIN 53 0.0050
691 BACK INJURY 54 0.0050
692 COORDINATION ABNORMAL 69 0.0049
693 DEEP VEIN THROMBOSIS 321 0.0049
694 CONSTIPATION 1077 0.0049
695 EAR PAIN 96 0.0049
696 BRAIN OEDEMA 62 0.0049
697 FLATULENCE 278 0.0049
698 VERTIGO 298 0.0049
699 GAIT DISTURBANCE 930 0.0049
700 BLOOD GLUCOSE DECREASED 233 0.0048
701 CHOLESTASIS 93 0.0048
702 SURGERY 283 0.0048
703 MENTAL IMPAIRMENT 116 0.0048
704 CYSTITIS 152 0.0048
705 PULMONARY THROMBOSIS 52 0.0048
706 BLOOD COUNT ABNORMAL 72 0.0047
707 SEROTONIN SYNDROME 91 0.0047
708 PHOTOPHOBIA 89 0.0047
709 SCAR 81 0.0047
710 MASS 66 0.0047
711 PANCREATITIS ACUTE 106 0.0047
712 INTERSTITIAL LUNG DISEASE 228 0.0047
713 FOETAL EXPOSURE DURING PREGNANCY 382 0.0047
714 THROMBOSIS 378 0.0047
715 AGEUSIA 117 0.0047
716 THERAPY NON-RESPONDER 210 0.0047
717 BLOOD PRESSURE INCREASED 708 0.0046
718 CHOKING 90 0.0046
719 DRY SKIN 614 0.0046
720 SINUS DISORDER 91 0.0046
721 SOMNOLENCE 925 0.0046
722 CARPAL TUNNEL SYNDROME 64 0.0046
723 BLOOD GLUCOSE FLUCTUATION 50 0.0046
724 BACTERIAL INFECTION 85 0.0046
725 SKIN INFECTION 51 0.0045
726 EMOTIONAL DISTRESS 547 0.0045
727 ERECTILE DYSFUNCTION 116 0.0045
728 ARTHRITIS 353 0.0045
729 PRURITUS GENERALISED 97 0.0045
730 SCAB 51 0.0045
731 NEUROLEPTIC MALIGNANT SYNDROME 53 0.0045
732 PRESCRIBED UNDERDOSE 89 0.0045
733 NEPHROLITHIASIS 204 0.0044
734 AGITATION 325 0.0044
735 DRY MOUTH 359 0.0044
736 SWELLING 413 0.0044
737 PULMONARY EMBOLISM 416 0.0044
738 ORAL PAIN 98 0.0044
739 BLISTER 245 0.0044
740 GLYCOSYLATED HAEMOGLOBIN INCREASED 110 0.0044
741 CYST 54 0.0043
742 HEADACHE 2707 0.0043
743 PHOTOSENSITIVITY REACTION 71 0.0043
744 IMPAIRED HEALING 141 0.0043
745 ERUCTATION 83 0.0043
746 RASH GENERALISED 111 0.0043
747 OVERDOSE 922 0.0043
748 DISEASE PROGRESSION 505 0.0043
749 FULL BLOOD COUNT DECREASED 86 0.0043
750 RHINORRHOEA 274 0.0042
751 OSTEOPOROSIS 174 0.0042
752 ADVERSE DRUG REACTION 379 0.0042
753 BLOOD CHOLESTEROL INCREASED 196 0.0042
754 ALOPECIA 825 0.0042
755 DEVICE OCCLUSION 59 0.0042
756 VIRAL INFECTION 139 0.0042
757 GLAUCOMA 80 0.0041
758 LYMPHOMA 64 0.0041
759 DEPRESSION 939 0.0041
760 BODY TEMPERATURE INCREASED 84 0.0041
761 PHARYNGITIS 51 0.0041
762 ARTHRALGIA 1709 0.0041
763 APHONIA 57 0.0041
764 GASTRIC DISORDER 140 0.0041
765 WEIGHT INCREASED 913 0.0041
766 JOINT SWELLING 490 0.0041
767 TRANSAMINASES INCREASED 90 0.0040
768 HEPATIC FUNCTION ABNORMAL 151 0.0040
769 GASTROENTERITIS VIRAL 73 0.0040
770 DEATH 3471 0.0040
771 INTERVERTEBRAL DISC PROTRUSION 88 0.0040
772 QUALITY OF LIFE DECREASED 54 0.0040
773 SCIATICA 64 0.0040
774 DRUG ADMINISTRATION ERROR 123 0.0040
775 CHILLS 469 0.0040
776 FEELING COLD 111 0.0040
777 BLOOD TEST ABNORMAL 56 0.0040
778 RASH MACULO-PAPULAR 88 0.0040
779 MOBILITY DECREASED 284 0.0039
780 ABSCESS 63 0.0039
781 DYSGEUSIA 293 0.0039
782 MYALGIA 668 0.0039
783 TOOTHACHE 71 0.0039
784 UPPER LIMB FRACTURE 78 0.0039
785 PLATELET COUNT INCREASED 51 0.0039
786 PHARYNGEAL OEDEMA 60 0.0039
787 METASTASES TO BONE 64 0.0039
788 PANCREATITIS 206 0.0039
789 PARANOIA 67 0.0039
790 NERVOUSNESS 203 0.0039
791 OROPHARYNGEAL PAIN 359 0.0039
792 DEVICE FAILURE 59 0.0039
793 FACE OEDEMA 65 0.0039
794 SKIN HAEMORRHAGE 57 0.0038
795 TUBULOINTERSTITIAL NEPHRITIS 72 0.0038
796 DYSKINESIA 156 0.0038
797 ABDOMINAL PAIN LOWER 97 0.0038
798 THROAT IRRITATION 172 0.0038
799 TENDONITIS 59 0.0038
800 SWOLLEN TONGUE 119 0.0038
801 TREMOR 629 0.0038
802 HYPOAESTHESIA ORAL 57 0.0038
803 ROAD TRAFFIC ACCIDENT 158 0.0038
804 HEPATOTOXICITY 84 0.0038
805 LIVER INJURY 92 0.0037
806 HERNIA 72 0.0037
807 COMPLETED SUICIDE 308 0.0037
808 BONE MARROW FAILURE 75 0.0037
809 COVID-19 646 0.0037
810 SKIN CANCER 79 0.0037
811 SINUSITIS 374 0.0036
812 FEMUR FRACTURE 113 0.0036
813 HYPOAESTHESIA 546 0.0036
814 THIRST 65 0.0036
815 PROTEINURIA 69 0.0036
816 SWELLING FACE 235 0.0036
817 HYPOACUSIS 153 0.0036
818 CANDIDA INFECTION 60 0.0035
819 PARAESTHESIA 556 0.0035
820 NERVOUS SYSTEM DISORDER 110 0.0035
821 MOVEMENT DISORDER 112 0.0035
822 LYMPHADENOPATHY 123 0.0035
823 PRURITUS 1334 0.0035
824 METASTASES TO LIVER 61 0.0035
825 TOOTH DISORDER 77 0.0035
826 MUSCLE SPASMS 635 0.0035
827 ARTHROPATHY 192 0.0035
828 MUCOSAL INFLAMMATION 90 0.0034
829 EYE DISORDER 113 0.0034
830 NEUROPATHY PERIPHERAL 326 0.0034
831 KIDNEY INFECTION 67 0.0034
832 INFECTION 494 0.0034
833 MUSCLE TIGHTNESS 55 0.0034
834 HEAD DISCOMFORT 60 0.0034
835 NIGHT SWEATS 109 0.0034
836 ABNORMAL BEHAVIOUR 134 0.0034
837 COLITIS 128 0.0034
838 ABNORMAL DREAMS 93 0.0034
839 DISEASE RECURRENCE 160 0.0034
840 HERPES ZOSTER 193 0.0034
841 OSTEONECROSIS OF JAW 83 0.0034
842 INTESTINAL OBSTRUCTION 126 0.0033
843 IMPAIRED WORK ABILITY 71 0.0033
844 BONE PAIN 193 0.0033
845 ACUTE MYELOID LEUKAEMIA 51 0.0033
846 RASH ERYTHEMATOUS 156 0.0033
847 LUNG NEOPLASM MALIGNANT 134 0.0033
848 EOSINOPHILIA 57 0.0032
849 RASH PRURITIC 176 0.0032
850 INFLAMMATION 167 0.0032
851 CONTRAINDICATED PRODUCT ADMINISTERED 97 0.0032
852 RASH MACULAR 112 0.0032
853 BLOOD GLUCOSE ABNORMAL 59 0.0032
854 SPINAL FRACTURE 64 0.0032
855 IRRITABLE BOWEL SYNDROME 68 0.0032
856 SEDATION 82 0.0031
857 THINKING ABNORMAL 58 0.0031
858 HEPATIC ENZYME INCREASED 212 0.0031
859 FEEDING DISORDER 63 0.0031
860 GASTROINTESTINAL DISORDER 277 0.0031
861 DRUG EXPOSURE DURING PREGNANCY 105 0.0031
862 INFLUENZA 344 0.0031
863 ASTHMA 348 0.0031
864 BACK DISORDER 50 0.0031
865 PRODUCT QUALITY ISSUE 417 0.0031
866 FEELING HOT 188 0.0031
867 FEBRILE NEUTROPENIA 203 0.0031
868 AGGRESSION 153 0.0031
869 MIDDLE INSOMNIA 57 0.0030
870 MUSCULOSKELETAL DISORDER 58 0.0030
871 SNEEZING 68 0.0030
872 ERYTHEMA 622 0.0030
873 SLEEP DISORDER 213 0.0030
874 FRACTURE 57 0.0030
875 WRONG TECHNIQUE IN DRUG USAGE PROCESS 108 0.0030
876 POOR QUALITY SLEEP 64 0.0030
877 FOOT FRACTURE 56 0.0030
878 PSYCHOTIC DISORDER 87 0.0029
879 EXPOSURE DURING PREGNANCY 183 0.0029
880 LYMPHOCYTE COUNT DECREASED 52 0.0029
881 DERMATITIS 61 0.0029
882 GLOSSODYNIA 65 0.0029
883 DISCOMFORT 177 0.0029
884 PERITONITIS 60 0.0029
885 RASH 1254 0.0029
886 LIMB DISCOMFORT 89 0.0029
887 DEVICE DISLOCATION 125 0.0029
888 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 204 0.0029
889 MUSCULOSKELETAL STIFFNESS 248 0.0028
890 JOINT STIFFNESS 74 0.0028
891 CONJUNCTIVITIS 52 0.0028
892 EYE PAIN 158 0.0028
893 MOUTH ULCERATION 59 0.0028
894 PRODUCT PRESCRIBING ERROR 65 0.0027
895 HOSPITALISATION 415 0.0027
896 SKIN DISORDER 90 0.0027
897 LACRIMATION INCREASED 81 0.0027
898 NEURALGIA 65 0.0027
899 KNEE ARTHROPLASTY 55 0.0026
900 EYE SWELLING 97 0.0026
901 STOMATITIS 158 0.0026
902 HOT FLUSH 196 0.0026
903 EAR INFECTION 69 0.0026
904 DRUG EFFECT DECREASED 139 0.0026
905 FUNGAL INFECTION 86 0.0026
906 THROAT TIGHTNESS 69 0.0025
907 LEUKOPENIA 127 0.0025
908 DRUG INTOLERANCE 245 0.0025
909 NASOPHARYNGITIS 464 0.0025
910 FREQUENT BOWEL MOVEMENTS 68 0.0025
911 VAGINAL HAEMORRHAGE 109 0.0025
912 BURNING SENSATION 175 0.0025
913 NEUTROPENIA 337 0.0025
914 ANAPHYLACTIC SHOCK 63 0.0024
915 PANIC ATTACK 89 0.0024
916 INFLUENZA LIKE ILLNESS 200 0.0024
917 NIGHTMARE 84 0.0024
918 PLASMA CELL MYELOMA 94 0.0024
919 SUICIDE ATTEMPT 146 0.0024
920 DEPRESSED MOOD 127 0.0024
921 INCORRECT PRODUCT ADMINISTRATION DURATION 52 0.0024
922 WHITE BLOOD CELL COUNT DECREASED 260 0.0024
923 ANGER 81 0.0024
924 GYNAECOMASTIA 74 0.0024
925 CRYING 86 0.0024
926 INTENTIONAL OVERDOSE 145 0.0023
927 DRUG DOSE OMISSION 370 0.0022
928 OFF LABEL USE 1927 0.0022
929 MATERNAL EXPOSURE DURING PREGNANCY 194 0.0022
930 INFUSION RELATED REACTION 144 0.0022
931 DRY EYE 108 0.0022
932 NEOPLASM MALIGNANT 143 0.0021
933 PRODUCT USE ISSUE 398 0.0021
934 ECZEMA 110 0.0021
935 GAIT INABILITY 70 0.0021
936 INCORRECT DOSE ADMINISTERED 477 0.0021
937 IRRITABILITY 125 0.0021
938 INCORRECT DRUG ADMINISTRATION DURATION 58 0.0021
939 SEIZURE 237 0.0020
940 HYPERSENSITIVITY 377 0.0020
941 OSTEONECROSIS 66 0.0020
942 DEVICE MALFUNCTION 140 0.0020
943 MALIGNANT NEOPLASM PROGRESSION 201 0.0020
944 BREAST CANCER FEMALE 52 0.0019
945 UNDERDOSE 140 0.0019
946 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 92 0.0019
947 THERAPY CESSATION 98 0.0019
948 ANAPHYLACTIC REACTION 104 0.0019
949 SKIN EXFOLIATION 158 0.0019
950 DRUG EFFECT INCOMPLETE 68 0.0019
951 PRODUCT DOSE OMISSION 122 0.0019
952 ADVERSE EVENT 171 0.0019
953 OCULAR HYPERAEMIA 88 0.0019
954 DRUG INEFFECTIVE 2432 0.0018
955 URTICARIA 304 0.0018
956 EYE IRRITATION 104 0.0018
957 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 98 0.0018
958 DRUG-INDUCED LIVER INJURY 56 0.0018
959 NEUTROPHIL COUNT DECREASED 72 0.0018
960 EPILEPSY 54 0.0018
961 PANCREATIC CARCINOMA 51 0.0018
962 RHEUMATOID ARTHRITIS 197 0.0017
963 PRODUCT USE IN UNAPPROVED INDICATION 429 0.0017
964 INJECTION SITE HAEMORRHAGE 138 0.0017
965 THERAPEUTIC RESPONSE DECREASED 103 0.0017
966 DEVICE LEAKAGE 72 0.0017
967 BONE DENSITY DECREASED 52 0.0017
968 THERAPEUTIC RESPONSE UNEXPECTED 74 0.0016
969 MOOD SWINGS 52 0.0016
970 PRODUCT SUBSTITUTION ISSUE 89 0.0015
971 INCORRECT ROUTE OF DRUG ADMINISTRATION 54 0.0015
972 TREATMENT FAILURE 125 0.0015
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 298 0.0015
974 SYSTEMIC LUPUS ERYTHEMATOSUS 52 0.0015
975 ILLNESS 149 0.0014
976 THERAPY INTERRUPTED 103 0.0014
977 SUICIDAL IDEATION 128 0.0014
978 EXTRA DOSE ADMINISTERED 55 0.0014
979 SKIN IRRITATION 60 0.0013
980 BREAST CANCER 119 0.0013
981 DEVICE ISSUE 104 0.0012
982 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 198 0.0011
983 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 77 0.0011
984 SKIN BURNING SENSATION 74 0.0010
985 PROSTATE CANCER 83 0.0010
986 DRUG ABUSE 84 0.0010
987 PSORIASIS 127 0.0010
988 PRODUCT DOSE OMISSION ISSUE 282 0.0010
989 INJECTION SITE ERYTHEMA 110 0.0009
990 BLADDER CANCER 51 0.0009
991 INJECTION SITE PAIN 245 0.0008
992 ACCIDENTAL EXPOSURE TO PRODUCT 75 0.0007
993 INJECTION SITE BRUISING 57 0.0007
994 DRUG WITHDRAWAL SYNDROME 56 0.0006
995 NO ADVERSE EVENT 92 0.0005
996 DRUG DEPENDENCE 63 0.0004